Theralase(R) Closes Non-Brokered Private Placement Equity Financing
TORONTO, ON / ACCESSWIRE / June 30, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT) (OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic …
Weiterlesen »